A ten-year retrospective California Poison Control System experience with possible amatoxin mushroom calls

References

• Kent R, Olson CGS. Poisoning & drug overdose. 8th ed. New York: McGraw Hill, LLC; 2022.
   Google Scholar
• Ye Y, Liu Z. Management of Amanita phalloides poisoning: a literature review and update. J Crit Care. 2018;46:17–22. doi:10.1016/j.jcrc.2018.03.028.
   PubMed Web of Science ®Google Scholar
• Xue J, Lou X, Ning D, et al. Mechanism and treatment of alpha-amanitin poisoning. Arch Toxicol. 2023;97(1):121–131. doi:10.1007/s00204-022-03396-x.
   PubMed Web of Science ®Google Scholar
• Tan JL, Stam J, van den Berg AP, et al. Amanitin intoxication: effects of therapies on clinical outcomes - a review of 40 years of reported cases. Clin Toxicol. 2022;60(11):1251–1265. doi:10.1080/15563650.2022.2098139.
   PubMed Web of Science ®Google Scholar
• Trabulus S, Altiparmak MR. Clinical features and outcome of patients with amatoxin-containing mushroom poisoning. Clin Toxicol. 2011;49(4):303–310. doi:10.3109/15563650.2011.565772.
   Web of Science ®Google Scholar
• De Olano J, Wang JJ, Villeneuve E, et al. Current fatality rate of suspected cyclopeptide mushroom poisoning in the United States. Clin Toxicol. 2021;59(1):24–27. doi:10.1080/15563650.2020.1747624.
   PubMed Web of Science ®Google Scholar
• O’Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673–690. doi:10.1007/s11135-006-9018-6.
   Web of Science ®Google Scholar
• Bursac Z, Gauss CH, Williams DK, et al. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. doi:10.1186/1751-0473-3-17.
   PubMedGoogle Scholar
• Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79(3):340–349. doi:10.2105/ajph.79.3.340.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Ghosh JK. AIC, BIC and recent advances in model selection. In: Bandyopadhyay PS, Forster MR, editors. Handbook of the Philosophy of Science, Philosophy of Statistics. Vol. 7. North-Holland: Elsevier; 2011. p. 583–605.
   Google Scholar
• Diaz JH. Amatoxin-containing mushroom poisonings: species, toxidromes, treatments, and outcomes. Wilderness Environ Med. 2018;29(1):111–118. doi:10.1016/j.wem.2017.10.002.
   PubMed Web of Science ®Google Scholar
• Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001;61(14):2035–2063. doi:10.2165/00003495-200161140-00003.
   PubMed Web of Science ®Google Scholar
• Le Dare B, Ferron PJ, Gicquel T. Toxic effects of amanitins: repurposing toxicities toward new therapeutics. Toxins. 2021;13(6):417. doi:10.3390/toxins13060417.
   PubMed Web of Science ®Google Scholar
• Enjalbert F, Rapior S, Nouguier-Soule J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715–757. doi:10.1081/clt-120014646.
   PubMed Web of Science ®Google Scholar
• Woodle ES, Moody RR, Cox KL, et al. Orthotopic liver transplantation in a patient with amanita poisoning. JAMA. 1985;253(1):69–70. doi:10.1001/jama.1985.03350250077026.
   PubMed Web of Science ®Google Scholar
• Klein AS, Hart J, Brems JJ, et al. Amanita poisoning: treatment and the role of liver transplantation. Am J Med. 1989;86(2):187–193. doi:10.1016/0002-9343(89)90267-2.
   PubMed Web of Science ®Google Scholar
• Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol. 2005;42(2):202–209. doi:10.1016/j.jhep.2004.10.023.
   PubMed Web of Science ®Google Scholar
• Ferreira R, Romaozinho JM, Amaro P, et al. Assessment of emergency liver transplantation criteria in acute liver failure due to Amanita phalloides. Eur J Gastroenterol Hepatol. 2011;23(12):1226–1232. doi:10.1097/MEG.0b013e32834c7b8f.
   PubMed Web of Science ®Google Scholar
• Saller R, Brignoli R, Melzer J, et al. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed. 2008;15(1):9–20. doi:10.1159/000113648.
   PubMedGoogle Scholar
• Mitchell T, Spyker D. Is intravenous silibinin a failed antidote for the fulminant hepatic failure treatment of amatoxin mushroom poisoning? Interim results of the North American clinical trial. Clinical Toxicology. 2017;55(7):689–868.
   Web of Science ®Google Scholar
• Mitchell ST, Olson KR. Intravenous silibinin for the management amatoxin poisoning: first usage in an American cohort. Clin Toxicology. 2008;46(5):351–421.
   Web of Science ®Google Scholar
• Gores KM, Hamieh TS, Schmidt GA. Survival following investigational treatment of amanita mushroom poisoning: thistle or shamrock? Chest. 2014;146(4):e126–e9. doi:10.1378/chest.13-1573.
   PubMed Web of Science ®Google Scholar
• Locatelli CD, Travaglia A, Manzo L. Prolonged high-dose n-acetylcysteine treatment of Amanita phalloides and chlorinated hydrocarbon poisoning. Pharmacol Res. 1992;26:201. doi:10.1016/1043-6618(92)91111-S.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen Y, Gao Y, et al. N-acetylcysteine as a treatment for amatoxin poisoning: a systematic review. Clin Toxicol. 2020;58(11):1015–1022. doi:10.1080/15563650.2020.1784428.
   PubMed Web of Science ®Google Scholar
• Horowitz BZ. Silibinin: a toxicologist’s herbal medicine? Clin Toxicol. 2022;60(11):1194–1197.
   Web of Science ®Google Scholar
• Trakulsrichai S, Sriapha C, Tongpoo A, et al. Clinical characteristics and outcome of toxicity from amanita mushroom poisoning. Int J Gen Med. 2017;10:395–400. doi:10.2147/IJGM.S141111.
   PubMed Web of Science ®Google Scholar
• Lecot J, Cellier M, Courtois A, et al. Cyclopeptide mushroom poisoning: a retrospective series of 204 patients. Basic Clin Pharmacol Toxicol. 2023;132(6):533–542.
   PubMed Web of Science ®Google Scholar
• Dluholucky S, Snitkova M, Knapkova M, et al. Results of diagnostics and treatment of amanita phalloides poisoning in Slovakia (2004-2020). Toxicon. 2022;219:106927. doi:10.1016/j.toxicon.2022.09.013.
   PubMed Web of Science ®Google Scholar
• Karvellas CJ, Tillman H, Leung AA, et al. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int. 2016;36(7):1043–1050. doi:10.1111/liv.13080.
   PubMed Web of Science ®Google Scholar
• Giannini L, Vannacci A, Missanelli A, et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol. 2007;45(5):539–542. doi:10.1080/15563650701365834.
   PubMed Web of Science ®Google Scholar
• Beuhler MC, Sasser HC, Watson WA. The outcome of North American pediatric unintentional mushroom ingestions with various decontamination treatments: an analysis of 14 years of TESS data. Toxicon. 2009;53(4):437–443. doi:10.1016/j.toxicon.2009.01.004.
   PubMed Web of Science ®Google Scholar
• Nordt SP, Manoguerra A, Clark RF. 5-Year analysis of mushroom exposures in California. West J Med. 2000;173(5):314–317. doi:10.1136/ewjm.173.5.314.
   PubMedGoogle Scholar